Muscle-specific expression of hepatitis B surface antigen: No effect on DNA-raised immune responses

被引:36
作者
Loirat, D
Li, ZL
Mancini, M
Tiollais, P
Paulin, D
Michel, ML
机构
[1] Inst Pasteur, INSERM, U163, Unite Recombinaison & Express Genet, F-75724 Paris 15, France
[2] Inst Pasteur, Stn Cent Microscopie Electron, F-75724 Paris, France
关键词
D O I
10.1006/viro.1999.9795
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The injection of plasmid DNA encoding hepatitis B virus (HBV) envelope proteins in mouse muscle leads to the induction of specific humoral and cellular immune responses. Most studies on DNA-based immunization have used viral promoters to drive antigen expression. In this study, we compared the efficiency of a muscle-specific promoter, the human desmin gene promoter, with the commonly used cytomegalovirus (CMV) early gene promoter. We showed that increased in vitro expression of HBV envelope proteins from the human desmin gene promoter has no effect on the in vivo immune response even after the injection of as little as 10 mu g of DNA. The injection of vectors encoding HBV envelope proteins under the control of either the human desmin gene promoter or the CMV promoter induced humoral and cytotoxic immune responses at comparable levels and of the same duration. The recruitment of antigen-presenting cells to the DNA injection site by pretreatment of muscle with a necrotizing agent increases the precocity and the intensity of the responses, particularly when the nonspecific CMV vector was used. (C) 1999 Academic Press.
引用
收藏
页码:74 / 83
页数:10
相关论文
共 48 条
[1]   DNA vaccination: Transfection and activation of dendritic cells as key events for immunity [J].
Akbari, O ;
Panjwani, N ;
Garcia, S ;
Tascon, R ;
Lowrie, D ;
Stockinger, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (01) :169-177
[2]  
ANDO K, 1994, J IMMUNOL, V152, P3245
[3]   Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination [J].
Boyer, JD ;
Ugen, KE ;
Wang, B ;
Agadjanyan, M ;
Gilbert, L ;
Bagarazzi, ML ;
Chattergoon, M ;
Frost, P ;
Javadian, A ;
Williams, WV ;
Refaeli, Y ;
Ciccarelli, RB ;
McCallus, D ;
Coney, L ;
Weiner, DB .
NATURE MEDICINE, 1997, 3 (05) :526-532
[4]   Enhanced response to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction [J].
Boyle, JS ;
Brady, JL ;
Lew, AM .
NATURE, 1998, 392 (6674) :408-411
[5]   Dual function of a human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte clone: Inhibition of HIV replication by noncytolytic mechanisms and lysis of HIV-infected CD4+ cells [J].
Buseyne, F ;
Fevrier, M ;
Garcia, S ;
Gougeon, ML ;
Riviere, Y .
VIROLOGY, 1996, 225 (01) :248-253
[6]   Antigen presentation by dendritic cells after immunization with DNA encoding a major histocompatibility complex class II-restricted viral epitope [J].
Casares, S ;
Inaba, K ;
Brumeanu, TD ;
Steinman, RM ;
Bona, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (09) :1481-1486
[7]  
Chattergoon MA, 1998, J IMMUNOL, V160, P5707
[8]  
CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333
[9]   Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2 [J].
Chow, YH ;
Huang, WL ;
Chi, WK ;
Chu, YD ;
Tao, MH .
JOURNAL OF VIROLOGY, 1997, 71 (01) :169-178
[10]   CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity [J].
Chu, RS ;
Targoni, OS ;
Krieg, AM ;
Lehmann, PV ;
Harding, CV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1623-1631